Tanaka, Y., Takahashi, Y., Kodama, A., Tanaka, R., & Saito, M. (2014). Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection. BioMed Central.
Citação norma ChicagoTanaka, Yuetsu, Yoshiaki Takahashi, Akira Kodama, Reiko Tanaka, and Mineki Saito. Neutralizing Antibodies against Human T Cell Leukemia Virus Type-I (HTLV-1) Eradicate HTLV-1 in Combination With Autologous Peripheral Blood Mononuclear Cells Via Antibody-dependent Cellular Cytotoxicity While Preventing New Infection. BioMed Central, 2014.
MLA citiranjeTanaka, Yuetsu, et al. Neutralizing Antibodies against Human T Cell Leukemia Virus Type-I (HTLV-1) Eradicate HTLV-1 in Combination With Autologous Peripheral Blood Mononuclear Cells Via Antibody-dependent Cellular Cytotoxicity While Preventing New Infection. BioMed Central, 2014.